Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer
NCT05446324
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
Gallium-68-tilmanocept
Sponsor
UMC Utrecht